NR3C2 and hepatocellular carcinoma: In addition to HK2 and LDHA, some researchers discovered that NR3C2 inhibits cellular aerobic glycolysis by regulating PKLR, an isozyme of pyruvate kinase, in hepatocellular carcinoma cells.15